Etropal AD (BUL:ETR)

Bulgaria · Delayed Price · Currency is BGN · Price in EUR

2.660

-0.100 (-3.62%)

At close: Aug 4, 2026

26.79% (1Y)

Market Cap	25.85M +26.1%
Revenue (ttm)	19.14M +13.3%
Net Income	-132.90K
EPS	-0.03
Shares Out	5.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,500
Open	2.660
Previous Close	2.760
Day's Range	2.660 - 2.660
52-Week Range	1.936 - 2.760
Beta	-0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 3, 2026

About Etropal AD

Etropal AD engages in the production and sale of disposable medical devices in Bulgaria. The company offers capillary dialyzers; arterial-venous blood line sets; procedure kits; and arterial-venous fistula needles. Etropal AD was founded in 1976 and is headquartered in Etropole, Bulgaria. Etropal AD is a subsidiary of Synthetica AD. [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 1976

Employees 100

Stock Exchange Bulgarian Stock Exchange

Ticker Symbol ETR

Full Company Profile

Financial Performance

In 2025, Etropal AD's revenue was 10.35 million, an increase of 28.28% compared to the previous year's 8.07 million. Earnings were 165,736, an increase of 271.63%.

Financial numbers in EUR Financial Statements